Boston Scientific Corp (BSX)

Industry Medical Devices


This stock can be held in an Investment ISA and an Investment Account
Sell

$62.23

Buy

$62.28

arrow-down$-0.52 (-0.83%)

Prices updated at 01 Apr 2026, 14:52 EDT
| Prices minimum 15 mins delay
|
Prices in USD

Boston Scientific Corp is a developer, manufacturer, and marketer of medical devices. The firm markets its devices to health-care professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Sector
Healthcare
Industry
Medical Devices
Chairman
Mr. Michael F. Mahoney
CEO
Mr. Michael F. Mahoney
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
59,000
Head office
300 Boston Scientific Way
Marlborough
United States
01752-1234
mobile
+1 508 683-4000
letter
BSXInvestorRelations@bsci.com

Key personnel

Salary
Mr. Yoshiaki Fujimori
Independent Director
0.15m
Mr. Christophe Pierre Weber
Director
-
Ms. Catherine R. Smith
Director
-
Mr. David C. Habiger
Independent Director
0.12m
Mr. Edward J. Ludwig
Lead Independent Director
0.17m
Mr. David S. Wichmann
Independent Director
0.15m
Ms. Ellen M. Zane
Independent Director
0.15m
Senator John E. Sununu
Independent Director
0.15m
Mr. Joseph M. Fitzgerald
Executive Vice President and Group President, Cardiovascular
0.89m
Mr. Michael F. Mahoney
Chairman of the Board, President and Chief Executive Officer
1.44m
Mr. Vance R. Brown
Executive Vice President, General Counsel and Corporate Secretary
0.66m
Dr. Cheryl B. Pegus, M.D.
Independent Director
0.12m
Mr. Arthur C. Butcher
Executive Vice President and Group President, MedSurg and Asia Pacific
0.74m
Mr. Jonathan R. Monson
Executive Vice President and Chief Financial Officer
0.59m
Dr. Jessica L. Mega, M.D.,M.P.H.
Independent Director
0.13m
Ms. Susan E. Morano
Independent Director
0.13m
Ms. Emily M. Woodworth
Senior Vice President, Global Controller and Chief Accounting Officer
-
Ms. Catherine R. Smith
Independent Director
-
Ms. Miriam O’Sullivan
Senior Vice President and Chief Human Resources Officer
-
Mr. Padraig A. O’Connor
Executive Vice President, Global Operations
-

Top 5 shareholders

No. of shares
BlackRock Inc145,175,869
Vanguard Group Inc139,685,997
FMR Inc97,386,941
Fidelity Management and Research Company97,386,941
Fidelity Management & Research Company LLC75,436,807

Director dealings

Action
01 Dec 2025-
01 Dec 2025-
01 Dec 2025-
01 Dec 2025-
01 Dec 2025-
01 Dec 2025-
01 Dec 2025-
01 Dec 2025-
01 Dec 2025-
28 Nov 2025-
12 Nov 2025-
14 Nov 2025-
06 Nov 2025-
03 Nov 2025-
03 Nov 2025-
03 Nov 2025-
03 Nov 2025-
03 Nov 2025-
29 Oct 2025-
29 Oct 2025-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.